These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 583343)

  • 1. In vitro production of thyroid-binding antibodies by peripheral blood lymphocytes from patients with Graves' disease: nonspecific responses associated with culture supernatant proteins.
    Wall JR; Strakosch CR; Trewin A; Joyner DM
    J Endocrinol Invest; 1979; 2(3):261-6. PubMed ID: 583343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide.
    Wall JR; Strakosch CR; Fang SL; Ingbar SH; Braverman LE
    Clin Endocrinol (Oxf); 1979 Jan; 10(1):79-91. PubMed ID: 582025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
    Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid antigen stimulates lymphocytes from patients with Graves' disease to produce thyroid-stimulating immunoglobulin (TSI).
    Knox AJ; von Westarp C; Row VV; Volpé R
    J Clin Endocrinol Metab; 1976 Aug; 43(2):330-7. PubMed ID: 181397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection.
    Yokoyama N; Izumi M; Katamine S; Nagataki S
    J Clin Endocrinol Metab; 1987 Feb; 64(2):215-8. PubMed ID: 2878934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
    Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
    J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease.
    Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Tezuka H; Nakao H; Kawakami A; Migita K; Ishikawa
    J Clin Endocrinol Metab; 1989 Nov; 69(5):939-45. PubMed ID: 2793996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.
    Ueki Y; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1987 Nov; 65(5):922-8. PubMed ID: 2959679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K; Metcalfe R; Weetman AP
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid stimulating immunoglobulin (TSI) synthesis by pokeweed mitogen (PWM) stimulated peripheral blood lymphocytes (PBL) from Graves' disease (GD) patients.
    Pautard B; Rémy JJ; Charreire J
    Clin Exp Immunol; 1986 Nov; 66(2):435-42. PubMed ID: 2880683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic analyses and concanavalin-A-induced suppressor cell dysfunction of intrathyroidal lymphocytes from patients with Graves' disease.
    Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Nakao H; Kawakami A; Izumi M
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1018-24. PubMed ID: 2972737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal immunoregulation of in vitro antibody secretion in autoimmune thyroid disease.
    MacLean DB; Miller KB; Brown R; Reichlin S
    J Clin Endocrinol Metab; 1981 Oct; 53(4):801-5. PubMed ID: 6457056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological role of thyroid blocking antibody in patients with primary hypothyroidism.
    Tanaka H; Yamauchi K; Takagi S; Miura Y; Ando M; Takatsuki K; Saito H; Matsui N
    Endocrinol Jpn; 1987 Oct; 34(5):689-99. PubMed ID: 2893730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen.
    McLachlan SM; Dickinson AM; Malcolm A; Farndon JR; Young E; Proctor SJ; Smith BR
    Clin Exp Immunol; 1983 Apr; 52(1):45-53. PubMed ID: 6602673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid-stimulating antibody (TSab) detected in sera of Graves' patients using human thyroid cell cultures.
    Toccafondi RS; Aterini S; Medici MA; Rotella CM; Tanini A; Zonefrati R
    Clin Exp Immunol; 1980 Jun; 40(3):532-9. PubMed ID: 6251989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of the production of human thyroid-stimulating immunoglobulins (HTSI) by Graves' lymphocytes cultured in vitro with phytohaemagglutinin (PHA).
    Knox AJ; von Westarp C; Row VV; Volpé R
    Metabolism; 1976 Nov; 25(11):1217-23. PubMed ID: 185485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro lymphocyte proliferation in response to polyclonal activators and microbial antigens, and production of immunoglobulins stimulating thyroid adenylate cyclase in Graves' disease.
    Bech K; Andersen V; Madsen SN
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):252-5. PubMed ID: 6896786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb.
    Ochi Y; Kajita Y; Hachiya T; Hamaoki M
    Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.